Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
British Journal of Pharmacology|December 20, 2023
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptorsStephen P H Alexander, Doriano Fabbro, Eamonn Kelly, et al.
British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: EnzymesStephen Ph Alexander, Doriano Fabbro, Eamonn Kelly, et al.
Molecular Pharmacology|September 7, 2017
NO-Sensitive Guanylate Cyclase Isoforms NO-GC1 and NO-GC2 Contribute to Noise-Induced Inner Hair Cell SynaptopathyDorit Möhrle, Katrin Reimann, Steffen Wolter, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 2015
Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor SignalingJulia Straubinger, Verena Schöttle, Nadja Bork, et al.
The Journal of Biological Chemistry|July 5, 2011
A phosphodiesterase 2A isoform localized to mitochondria regulates respirationRebeca Acin-Perez, Michael Russwurm, Kathrin Günnewig, et al.
Kidney International|July 9, 2010
Decreased renal corin expression contributes to sodium retention in proteinuric kidney diseasesDanny Polzin, Henriette J Kaminski, Christian Kastner, et al.
Circulation Research|June 27, 2013
Transgenic mice for cGMP imagingMartin Thunemann, Lai Wen, Matthias Hillenbrand, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptorsStephen P H Alexander, Doriano Fabbro, Chloe J Peach, et al.
Nature|November 12, 2013
Dysfunctional nitric oxide signalling increases risk of myocardial infarctionJeanette Erdmann, Klaus Stark, Ulrike B Esslinger, et al.
Circulation|June 12, 2020
Phosphodiesterase 3A and Arterial HypertensionMaria Ercu, Lajos Markó, Carolin Schächterle, et al.
Pageof 10